Active Pharmaceutical Ingredient (API) Market Size 2022, Share, Key Players Analysis Report and Forecast to 2027
In 2022, Pfizer entered into an agreement with Acuitas to deliver a lipid nanoparticle delivery system for use in mRNA vaccines such as COMIRNATY ((tozinameran) and therapeutics.
View full press release